These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9443 related articles for article (PubMed ID: 1420853)

  • 21. Dysplastic nevi in relation to superficial spreading melanoma.
    Titus-Ernstoff L; Barnhill RL; Duray PH; Ernstoff MS; Kirkwood JM
    Cancer Epidemiol Biomarkers Prev; 1993; 2(2):99-101. PubMed ID: 8467253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant melanoma and nevocellular nevi. Histogenesis and relationships. Fluorescence-microscopic and catamnestic photographic studies.
    Paul E
    Norm Pathol Anat (Stuttg); 1984; 48():1-112. PubMed ID: 6701085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A retrospective look at dysplastic nevi. What were they in 1978 and how have they fared since?
    Cockerell CJ; Berson DS
    Am J Dermatopathol; 1985; 7 Suppl():93-7. PubMed ID: 3940095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Size overlap between benign melanocytic choroidal nevi and choroidal malignant melanomas.
    Augsburger JJ; Corrêa ZM; Trichopoulos N; Shaikh A
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2823-8. PubMed ID: 18408179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of the anatomic distribution of cutaneous melanoma in two populations with different levels of sunlight: the west of Scotland and Queensland, Australia 1982-2001.
    Whiteman DC; Bray CA; Siskind V; Hole D; MacKie RM; Green AC
    Cancer Causes Control; 2007 Jun; 18(5):485-91. PubMed ID: 17450418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
    Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
    Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Multiple primary malignant melanomas. A report of five cases (author's transl)].
    Prade M; Bognel C; Weill S; Sancho H; Petit JY; Charpentier P
    Sem Hop; 1979 Sep 8-15; 55(27-30):1312-6. PubMed ID: 228406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of BRAF T1799A(V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis.
    Wu J; Rosenbaum E; Begum S; Westra WH
    Am J Dermatopathol; 2007 Dec; 29(6):534-7. PubMed ID: 18032947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melanocytic lesions in a private pathology practice. Comparison of histologic features in different tumor types with particular reference to dysplastic nevi.
    Hastrup N; Hou-Jensen K
    APMIS; 1993 Nov; 101(11):845-50. PubMed ID: 8286092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas.
    Rhodes AR; Harrist TJ; Day CL; Mihm MC; Fitzpatrick TB; Sober AJ
    J Am Acad Dermatol; 1983 Oct; 9(4):563-74. PubMed ID: 6630618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysplasia, dysplastic melanocytes, dysplastic nevi, the dysplastic nevus syndrome, and the relation between dysplastic nevi and malignant melanomas.
    Ackerman AB; Mihara I
    Hum Pathol; 1985 Jan; 16(1):87-91. PubMed ID: 3972389
    [No Abstract]   [Full Text] [Related]  

  • 32. Cutaneous melanoma in women: anatomic distribution in relation to sun exposure and phenotype.
    Cress RD; Holly EA; Ahn DK; LeBoit PE; Sagebiel RW
    Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):831-6. PubMed ID: 8634653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spatial density of primary malignant melanoma in sun-shielded body sites: A potential guide to melanoma genesis.
    Ragnarsson-Olding BK
    Acta Oncol; 2011 Apr; 50(3):323-8. PubMed ID: 21299449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous malignant melanoma and oculodermal melanocytosis (nevus of Ota): report of a case and review of the literature.
    Patel BC; Egan CA; Lucius RW; Gerwels JW; Mamalis N; Anderson RL
    J Am Acad Dermatol; 1998 May; 38(5 Pt 2):862-5. PubMed ID: 9591805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined Clark's nevus.
    Marchesi L; Naldi L; Locati F; Tribbia G; Pezzica E; Parma A; Cainelli T
    Am J Dermatopathol; 1994 Aug; 16(4):364-71. PubMed ID: 7978065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in the site distribution of common melanoma subtypes in Queensland, Australia over time: implications for public health campaigns.
    Youl PH; Youlden DR; Baade PD
    Br J Dermatol; 2013 Jan; 168(1):136-44. PubMed ID: 22612718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex differences in numbers of nevi on body sites of young European children: implications for the etiology of cutaneous melanoma.
    Autier P; Boniol M; Severi G; Pedeux R; Grivegnée AR; Doré JF
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2003-5. PubMed ID: 15598754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased intraepidermal melanocyte frequency and size in dysplastic melanocytic nevi and cutaneous melanoma. A comparative quantitative study of dysplastic melanocytic nevi, superficial spreading melanoma, nevocellular nevi, and solar lentigines.
    Rhodes AR; Melski JW; Sober AJ; Harrist TJ; Mihm MC; Fitzpatrick TB
    J Invest Dermatol; 1983 May; 80(5):452-9. PubMed ID: 6341476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nodular melanomas associated with nevi.
    Manganoni AM; Farisoglio C; Gavazzoni F; Facchetti F; Zanotti F; Calzavara-Pinton P
    J Am Acad Dermatol; 2010 Nov; 63(5):e97. PubMed ID: 20950735
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinicopathological features and prognosis of patients with de novo versus nevus-associated melanoma in Taiwan.
    Sheen YS; Liao YH; Lin MH; Chen JS; Liau JY; Liang CW; Chang YL; Chu CY
    PLoS One; 2017; 12(5):e0177126. PubMed ID: 28472158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 473.